- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04188886
Evaluation of Practices of ECMO or ECLS and Ethical Implications in France (EVAPE)
Evaluation of the Daily Practices of ECMO Veino-arterial and Their Ethical Implications in France: Multicenter Observational Study (Evaluation of Professional Practice)
Short-term circulatory support (ECMO/ECLS) has become a common emergency resuscitation support.
Currently, the indication of the ECMO/ECLS relies more on clinic, biological and imagery arguments than on a real consensus.During the care of a patient under ECMO/ECLS, various stakeholders are involved in the implementation and its medical and paramedical management. Everyone, with their knowledge and experience, has an opinion on the relevance of this therapy.
Study Overview
Detailed Description
A validated questionnaire, translated from an Anglo-Saxon study, will be used as a basis for work and adapted. After the publication of a memo, it is accessible anonymously on a platform (ASKABOX) whose link is distributed by email by the secretaries or nursing staff. The city and the exercise service will be requested in the preamble of the questionnaire. It is composed of six demographic questions: age, gender, occupation, participation in emergency care, number of ECMOs encountered, level of knowledge about ECMO. The other questions concern concrete ECMO situations and the answers are nuanced from definitely yes to definitely no to allow professionals to express their opinion as well as possible. The targeted professionals are all those involved in the management of patients on ECMO: emergency physicians, anesthesiologists, surgeons, perfusionists, nurses, orderlies, ASHs.
A monocentric feasibility study was carried out with satisfactory results in terms of participation.
AN INFORMATION NOTE WILL BE ATTACHED WITH THE EMAIL AND THE LINK FOR THE QUESTIONNAIRE (ANONYMOUS)
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Dijon, France, 21000
- Recruiting
- CHU Bourgogne Franche Comté
-
Contact:
- Elodie BERG, MD
- Phone Number: +33-380281294
- Email: elodie.berg.eb@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- All medical and paramedical personnel involved in decision making, installation, and monitoring of the ECMO
Exclusion Criteria:
- MEDICAL AND PARAMEDICAL STAFF NOT INVOLVED IN THE ESTABLISHMENT OR FOLLOW-UP OF THE ECMO
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation the involvement of professionals in ECMO-related decisions
Time Frame: 1 day
|
Through an anonymous questionnaire, the investigators will evaluate the speciality (eg cardiac surgeon, anesthesiologist...) of the doctor responsible for the indication of ECLS
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of the profession of each person involved in the management of the patients
Time Frame: 1 day
|
Through an anonymous questionnaire, identifying the profession of each person involved in the management of the patients
|
1 day
|
|
Demographic data (age, sexe) of each personnel involved in the management of the patients
Time Frame: 1 day
|
Through an anonymous questionnaire, identifying the demographic data of the health care staff involved in the care management of the patients
|
1 day
|
|
Level of training and knowledge of each personnel involved in the management of the patients
Time Frame: 1 day
|
Through an anonymous questionnaire, identifying the level of training and knowledge of the health care staff involved in the care management of the patients
|
1 day
|
|
Opinion of the health care staff on the care management of the patients
Time Frame: 1 day
|
Through an anonymous questionnaire, clarify the opinion of health care staff on care management
|
1 day
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ElodieBERG2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.